Abstract
Serial measurements of vital capacity were obtained in 11 patients with impaired pulmonary function due to sarcoidosis during 12 courses of corticosteroid treatment. Vital capacity improved promptly and approached a maximum value in about three weeks. A three week trial is probably sufficient to show whether or not corticosteroids are effective in a patient with sarcoidosis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Colp C., Park S. S., Williams M. H., Jr Pulmonary function follow-up to 120 patients with sarcoidosis. Ann N Y Acad Sci. 1976;278:301–307. doi: 10.1111/j.1749-6632.1976.tb47041.x. [DOI] [PubMed] [Google Scholar]
- Emirgil C., Sobol B. J., Williams M. H., Jr Long-term study of pulmonary sarcoidosis. The effect of steroid therapy as evaluated by pulmonary function studies. J Chronic Dis. 1969 Jul;22(2):69–86. doi: 10.1016/0021-9681(69)90060-5. [DOI] [PubMed] [Google Scholar]
- Johns C. J., Zachary J. B., Ball W. C., Jr A ten-year study of corticosteroid treatment of pulmonary sarcoidosis. Johns Hopkins Med J. 1974 May;134(5):271–283. [PubMed] [Google Scholar]
- Selroos O., Sellergren T. L. Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease. Scand J Respir Dis. 1979 Aug;60(4):215–221. [PubMed] [Google Scholar]
- Sharma O. P., Colp C., Williams M. H., Jr Course of pulmonary sarcoidosis with and without corticosteriod therapy as determined by pulmonary function studies. Am J Med. 1966 Oct;41(4):541–551. doi: 10.1016/0002-9343(66)90216-6. [DOI] [PubMed] [Google Scholar]